Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Solid Biosciences (SLDB) Gross Profit: 2022-2024

Historic Gross Profit for Solid Biosciences (SLDB) over the last 2 years, with Dec 2024 value amounting to -$75,000.

  • Solid Biosciences' Gross Profit rose 25.74% to -$75,000 in Q4 2024 from the same period last year, while for Dec 2024 it was -$340,000, marking a year-over-year increase of 22.55%. This contributed to the annual value of -$340,000 for FY2024, which is 22.73% up from last year.
  • Latest data reveals that Solid Biosciences reported Gross Profit of -$75,000 as of Q4 2024, which was up 8.54% from -$82,000 recorded in Q3 2024.
  • Solid Biosciences' Gross Profit's 5-year high stood at $1.9 million during Q2 2022, with a 5-year trough of -$121,000 in Q1 2023.
  • In the last 3 years, Solid Biosciences' Gross Profit had a median value of -$95,000 in 2024 and averaged $127,333.
  • In the last 5 years, Solid Biosciences' Gross Profit slumped by 105.77% in 2023 and then rose by 25.74% in 2024.
  • Over the past 3 years, Solid Biosciences' Gross Profit (Quarterly) stood at $1.9 million in 2022, then slumped by 105.77% to -$101,000 in 2023, then climbed by 25.74% to -$75,000 in 2024.
  • Its Gross Profit stands at -$75,000 for Q4 2024, versus -$82,000 for Q3 2024 and -$88,000 for Q2 2024.